Dihydroorotate Dehydrogenase Inhibitor, Brequinar
CAS: 96201-88-6
Ref. 3D-WDA20188
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Dihydroorotate Dehydrogenase Inhibitor, Brequinar
Sinónimos:
- Brequinar sodium
- Nsc-368390
- DuP-785
- Sodium 6-Fluoro-2-(2'-Fluorobiphenyl-4-Yl)-3-Methylquinoline-4-Carboxylate
Descripción:
Brequinar is a dihydroorotate dehydrogenase inhibitor that has been shown to inhibit the mitochondrial function and replication of DNA. The drug is used in combination therapy with other agents, such as uridine, for the treatment of colon cancer. Brequinar works by inhibiting the formation of dihydroorotate, which is an intermediate in pyrimidine synthesis. It also has immunosuppressive properties and can be used for the treatment of autoimmune diseases.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
397.35 g/mol
Fórmula:
C23H14F2NNaO2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
